Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular and Metabolic Adaptations to Intermittent Hypoxia
NCT02058823Phase 4Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Aug 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in obstructive sleep apnea (OSA), sponsored by CHU Grenoble Alpes. Started Aug 2013; status: terminated.
02
Drugs
valsartan
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT02058823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058823.